Biosite® Inc. Web Site -- Triage System

By: Alere  09-12-2011

Triage® Meters

Triage® Meters are designed to provide diagnostic results quickly and easily. Quantitative diagnostic panel results are displayed and printed in easy to read numbers and highlighted when the result is above the cutoff. Qualitative diagnostic panel results are displayed as positive (POS) or negative (NEG), eliminating the need for interpretation of lines that often hamper qualitative diagnostics.

Cardiovascular Diseases


  • An immunoassay that measures B-type Natriuretic Peptide (BNP) in whole blood or plasma, used:
    • as an aid in the diagnosis of CHF
    • as an aid in the assessment of severity of CHF
    • for the risk stratification of patients with ACS
    • for the risk stratification of patients with HF

  • An immunoassay for the quantitative determination of CK-MB, myoglobin, and troponin I in whole blood or plasma, as an aid in the diagnosis of acute myocardial infarction.

  • An immunoassay for use as an aid in the diagnosis of acute myocardial infarction, the diagnosis and assessment of severity of congestive heart failure, and the risk stratification of patients with acute coronary syndromes and congestive heart failure. One panel combines troponin I, CK-MB, myoglobin, and BNP to provide rapid, accurate results in whole blood and plasma.

  • An immunoassay for use as an aid in the diagnosis of myocardial infarction, the diagnosis and assessment of severity of heart disease, the assessment and evaluation of patients suspected of having disseminated intravascular coagulation and thromboembolic events including pulmonary embolism and DVT, and the risk stratification of patients with acute coronary syndromes and congestive heart failure. One panel combines BNP, CK-MB, D-dimer, myoglobin and troponin I.

  • An immunoassay for use as an aid in the assessment and evaluation of patients suspected of having disseminated intravascular coagulation or thromboembolic events including pulmonary embolism (PE).
  • NEW! (Not available in the USA)
    Biosite proudly announces the availability of the Triage® NGAL Test for the rapid quantitative determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL). With the simple application of ~250 µl of EDTA anticoagulated whole blood or plasma, it provides a quantitative result in approximately 15 minutes at either the point of care or in the clinical lab. This test requires no sample processing, precision pipetting or daily liquid controls and runs on the established Triage® Meters, which are widely deployed throughout the world.

Drug Screening


  • A fluorescence immunoassay intended to be used with the Triage® Meters for the point-of-care qualitative determination of major metabolites of amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, opiates, phencyclidine, THC and trycylic antidepressants in urine.


Other products and services from Alere

09-12-2011

Biosite® Inc. Web Site -- Cardiac Panel

Finally, technology that has caught up with your needs.Rapid, quantitative measurement of CK-MB, myoglobin, and troponin I to aid in the diagnosis of acute myocardial infarction. Rapid, actionable information to aid in the diagnosis of acute myocardial infarction. Enables triage decisions in under two hours when used with accelerated protocol 1. Simultaneous cardiac marker results from whole blood in approximately 15 minutes.


09-12-2011

Biosite® Inc. Web Site -- D-Dimer Test

A rapid, quantitative immunoassay to aid in the assessment and evaluation of patients suspected of having disseminated intravascular coagulation and thromboembolic events including pulmonary embolism and deep vein thrombosis. Performed on the Triage Meters.


09-12-2011

Biosite® Inc. Web Site -- Products

Through combined expertise in diagnostic discovery and commercialization, Biosite is focused on developing novel diagnostics tests that are capable of immediately and accurately diagnosing and assessing critical conditions, which can take several hours or even days using conventional testing methods.


09-12-2011

Biosite® Inc. Web Site -- Profiler Shortness of Breath

The Triage® Profiler Shortness of Breath Panel provides rapid risk assessment and differential diagnosis of patients presenting to the emergency department with shortness of breath and risk assessment of patients with acute coronary syndromes. Troponin I, CK-MB, myoglobin, BNP and D-dimer each provide unique clinical information, and the panel approach maximizes the strengths of each marker.


09-12-2011

Biosite® Inc. Web Site -- TOX Drug Screen -- TOX Drug Screen

According to the National Academy of Clinical Biochemistry, Laboratory Medicine Practice Guidelines, stat toxicology assays required to support an ED should have a turnaround time of one hour or less. The Value of Point-of-Care Drug Testing Nearly every day patients are treated in emergency departments across the country for complications due to drug overdose.


09-12-2011

Biosite® Inc. Web Site -- Triage® BNP Test

The Triage BNP Test is intended for use with the Triage Meters for the rapid in vitro quantitative measurement of B-Type Natriuretic Peptide in human whole-blood or plasma specimens using EDTA as the anticoagulant. 98 percent diagnostic accuracy in initial studies versus all other clinical findings in patients with or without disease history3.